Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Completed · Phase 3 · Has a placebo group

Conditions studied: Arthritis, Rheumatoid

In brief

This study will test if CP-690,550 is safe and effective in rheumatoid arthritis patients taking methotrexate who have an inadequate response to tumor necrosis factor inhibitor treatment.

Key facts

Study ID

NCT00960440

Run by

Pfizer

People needed

399

Starts

2009-10-01

Expected to finish

2011-03-01

Last updated by the study team

2018-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with moderate to severe rheumatoid arthritis on a stable dose of methotrexate who have inadequate response to Tumor Necrosis Factor (TNF) inhibitors.

You may not qualify if…

• Pregnancy, severe acute or chronic medical conditions, including serious infections or clinically significant laboratory abnormalities.

Where it is running

• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Farmington, Connecticut, United States
• Pfizer Investigational Site — Trumbull, Connecticut, United States
• Pfizer Investigational Site — Aventura, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Boise, Idaho, United States
• Pfizer Investigational Site — Idaho Falls, Idaho, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — New Orleans, Louisiana, United States
• Pfizer Investigational Site — Portland, Maine, United States
• Pfizer Investigational Site — Cumberland, Maryland, United States
• Pfizer Investigational Site — Worcester, Massachusetts, United States
• Pfizer Investigational Site — Flowood, Mississippi, United States
• Pfizer Investigational Site — Tupelo, Mississippi, United States
• Pfizer Investigational Site — Lebanon, New Hampshire, United States
• Pfizer Investigational Site — Voorhees Township, New Jersey, United States
• Pfizer Investigational Site — Rocky Mount, North Carolina, United States
• Pfizer Investigational Site — Bethlehem, Pennsylvania, United States
• Pfizer Investigational Site — Willow Grove, Pennsylvania, United States
• Pfizer Investigational Site — Wyomissing, Pennsylvania, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.